Boehringer Ingelheim said that it stood behind the safety of Pradaxa and believed the lawsuits lacked merit, but that settling the case allowed it to move on.
via NYT > Health http://ift.tt/1iuaEG4
via All Health and Fitness http://ift.tt/1iucnes
No comments:
Post a Comment